This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
ETFs to Win/Lose Amid Rising Inflationary Bets
by Sanghamitra Saha
Vaccine distribution and a likely fat federal spending bill under the Biden administration have led to a rise in future economic growth forecasts, which in turn boosted bets over rising inflation.
Yields Head for Big Monthly Gain: ETFs to Win & Lose
by Sweta Killa
The 10-year yields are on track for their largest monthly gain in three years, having gained 26 bps so far in February.
U.S. Dollar Rising: ETF Winners & Losers
by Sanghamitra Saha
After a rough year, the U.S. dollar started gaining ground this year. While small-cap stocks and some currency-hedged international investments will gain, large-caps and commodities may lose ahead.
5 ETFs to Benefit From Treasury Yield Surge
by Sanghamitra Saha
Rates have been rising fast in the United States over the past few weeks on growing risk appetite and reflationary optimism.
Time for Emerging Market ETFs?
by Sanghamitra Saha
EMs have suffered a lot amid the pandemic. Undervaluation, better growth prospects, massive Fed rate cut, higher interest rates in EMs have opened up opportunities for EM ETFs now.
Disinflation in Emerging Markets? Buy EM Bond ETFs
by Sanghamitra Saha
Prospects for disinflation in the emerging market economies are likely to boost EM bond ETF inflows as reflationary trend may hurt U.S. bond market.
U.S. Dollar Sees First Drop Since 2017: ETFs & Stocks to Buy
by Sweta Killa
The super-easy policies by the Fed and the central government as well as a series of vaccine development have pushed the U.S. dollar down.
The Best Currency ETF of 2020 Will Surprise You
by Sanghamitra Saha
Chinese yuan has come across as the best currency ETF of 2020.
Dollar Declines: What Awaits the Currency ETFs in 2021?
by Sanghamitra Saha
This has been a rough year for the greenback with a good start but poor finish.
ETF Asset Report of October
by Sanghamitra Saha
Election uncertainty, failed talks over the virus-related stimulus bill, subdued tech earnings and rising coronavirus cases on the global front added to Wall Street's woes.